# Neurocrine Biosciences Inc – FDA Inspection, Jul 18, 2024

Source: https://www.keypedia.com/records/fda_inspections/neurocrine-biosciences-inc/d7a6a21a-b605-42d6-8f34-1c4aee5aa3ff
Source feed: FDA_Inspections

> FDA inspection 1244087 of Neurocrine Biosciences Inc, July 18, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 314. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1244087
- Company Name: Neurocrine Biosciences Inc
- Inspection Date: 2024-07-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarket Surv. and Epidemiology
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 998843 - 2016-12-02

## Related Officers

- [Investigator](https://www.keypedia.com/people/lan-t-tran/ab9c1008-c03f-425f-ac3c-a569d3e5037c)
- [Issuing Officer](https://www.keypedia.com/people/theressa-b-smith/80f0c339-7eac-4c73-b9f6-ecb368738fe6)

Company: https://www.keypedia.com/companies/neurocrine-biosciences-inc/6c40dcc4-1aa2-43ea-ac52-032e79ec83c0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c